)
Quipt Home Medical (QIPT) investor relations material
Quipt Home Medical Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2025 revenue was $58.3M, down 4.1% year-over-year but up 1.6% sequentially, with a net loss of $3.0M ($0.07/diluted share), driven by reimbursement changes, contract losses, and a cybersecurity incident.
Adjusted EBITDA for Q3 2025 was $13.7M (23.5% margin), a 3.6% decrease year-over-year, but margin remained stable; operating cash flow for the nine months was $27.9M, up from $25.4M in the prior year.
Revenue stabilization and a return to positive organic growth were driven by core therapies, improved referral volumes, and operational improvements.
Expanded healthcare system partnerships, including a milestone transaction with Ballad Health and a joint venture with major Midwest health systems, enhanced discharge integration and market reach.
The company is focused on organic growth, operational profitability, expanding product and service reach, and optimizing efficiencies.
Financial highlights
Q3 2025 revenue was $58.3M, down 4.1% year-over-year but up 1.6% sequentially; nine months ended June 30, 2025 revenue was $177.0M, down 4.1% year-over-year.
Adjusted EBITDA for Q3 2025 was $13.7M (23.5% margin); for the nine months, $41.0M (23.2% margin), both down year-over-year.
Net loss for Q3 2025 was $3M ($0.07/diluted share), compared to a $1.6M loss in Q3 2024; net loss for the nine months was $7.2M, up from $3.8M.
Cash flow from operations for the nine months ended June 30, 2025, was $27.9M, up from $25.4M in the prior year period.
Recurring revenue represented 81% of total Q3 2025 revenue.
Outlook and guidance
Confident in continued organic growth, margin stability, and further integration of recent acquisitions, with a focus on maximizing shareholder value.
Expect Heart Medical Equipment’s adjusted EBITDA margin to align with corporate averages within three quarters post-acquisition; acquired DME provider's margin expected to align within two quarters.
Ongoing expansion into new markets, including Michigan, and continued De Novo openings in Florida and Alabama.
Management expects current liquidity sources to be sufficient for the next twelve months.
Next Quipt Home Medical earnings date
Next Quipt Home Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage